Wells Fargo’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17K Sell
1,000
-952
-49% -$1.35K ﹤0.01% 6320
2025
Q4
$2.91K Hold
1,952
﹤0.01% 6180
2025
Q3
$4.22K Buy
1,952
+952
+95% +$1.76K ﹤0.01% 6094
2025
Q2
$1.58K Hold
1,000
﹤0.01% 6242
2025
Q1
$1.08K Hold
1,000
﹤0.01% 6233
2024
Q4
$696 Buy
+1,000
New +$925 ﹤0.01% 6292
2021
Q4
Sell
-1,000
Closed -$1K 7803
2021
Q3
$1K Buy
+1,000
New +$1.85K ﹤0.01% 6800
2021
Q2
Sell
-35,850
Closed -$99K 7436
2021
Q1
$99K Hold
35,850
﹤0.01% 5495
2020
Q4
$72K Buy
35,850
+25,000
+230% +$79K ﹤0.01% 5474
2020
Q3
$36K Sell
10,850
-22,722
-68% -$88.4K ﹤0.01% 5619
2020
Q2
$86K Hold
33,572
﹤0.01% 5290
2020
Q1
$27K Hold
33,572
﹤0.01% 5532
2019
Q4
$36K Hold
33,572
﹤0.01% 5608
2019
Q3
$41K Buy
+33,572
New +$46.3K ﹤0.01% 5618

Other funds holding TLSA

Wells Fargo's TLSA Position: Q1 2026 in Review

Wells Fargo reduced its Tiziana Life Sciences (TLSA) stake by 49% in Q1 2026, selling an estimated $1.35K and leaving 1,000 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #6320.

Wells Fargo first reported a position in TLSA in Q3 2019 and has held it in 14 quarters since. The position peaked at $99K in Q1 2021. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2026.

  • Wells Fargo held 1,000 shares of Tiziana Life Sciences worth $1.17K as of Q1 2026.
  • Wells Fargo sold 952 Tiziana Life Sciences shares in Q1 2026, an estimated $1.35K.
  • Tiziana Life Sciences made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6320 holding.
  • Wells Fargo first reported a position in Tiziana Life Sciences in Q3 2019 and has held it in 14 quarters since.
  • Wells Fargo's Tiziana Life Sciences position peaked at $99K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.